Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013174
Filing Date
2022-05-13
Accepted
2022-05-13 07:30:34
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 652690
2 ex3-1.htm EX-3.1 357731
3 ex3-2.htm EX-3.2 108931
4 ex10-1.htm EX-10.1 119809
5 ex31-1.htm EX-31.1 9293
6 ex31-2.htm EX-31.2 16495
7 ex32.htm EX-32 13462
8 ex10-1_001.jpg GRAPHIC 6244
9 ex10-1_002.jpg GRAPHIC 14426
10 ex10-1_003.jpg GRAPHIC 15759
  Complete submission text file 0001493152-22-013174.txt   4656635

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE abeo-20220331.xsd EX-101.SCH 28932
12 XBRL CALCULATION FILE abeo-20220331_cal.xml EX-101.CAL 55018
13 XBRL DEFINITION FILE abeo-20220331_def.xml EX-101.DEF 132665
14 XBRL LABEL FILE abeo-20220331_lab.xml EX-101.LAB 294713
15 XBRL PRESENTATION FILE abeo-20220331_pre.xml EX-101.PRE 232105
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 527470
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 22920242
SIC: 2834 Pharmaceutical Preparations